Price T Rowe Associates Inc Moon Lake Immunotherapeutics Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,613,233 shares of MLTX stock, worth $145 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,613,233

Previous 2,973,830 12.13%

Holding current value

$145 Million

Previous $116 Million 6.16%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$32.84 - $51.05 $11.8 Million - $18.4 Million	-360,597 Reduced 12.13%	2,613,233 $123 Million
Q1 2025 May 14, 2025	SELL	$36.75 - $54.34 $13.6 Million - $20.1 Million	-369,813 Reduced 11.06%	2,973,830 $116 Million
Q4 2024 Feb 14, 2025	BUY	$45.84 - $57.91 $16.7 Million - $21 Million	363,394 Added 12.19%	3,343,643 $181 Million
Q3 2024 Nov 14, 2024	BUY	$40.15 - $55.4 $16.8 Million - $23.2 Million	418,737 Added 16.35%	2,980,249 $150 Million
Q2 2024 Aug 14, 2024	BUY	$38.43 - $48.6 $16.4 Million - $20.7 Million	425,629 Added 19.93%	2,561,512 $113 Million
Q1 2024 May 15, 2024	SELL	$43.78 - $63.86 $7.8 Million - $11.4 Million	-178,129 Reduced 7.7%	2,135,883 $107 Million
Q4 2023 Feb 14, 2024	BUY	$36.35 - $63.02 $7.13 Million - $12.4 Million	196,144 Added 9.26%	2,314,012 $140 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $8.45 Million - $10.7 Million	174,812 Added 9.0%	2,117,868 $121 Million
Q2 2023 Aug 14, 2023	BUY	$19.01 - $51.79 $21.1 Million - $57.6 Million	1,112,150 Added 133.85%	1,943,056 $99.1 Million
Q1 2023 May 15, 2023	BUY	$11.03 - $23.7 $91,604 - $196,828	8,305 Added 1.01%	830,906 $17.8 Million
Q4 2022 Feb 14, 2023	SELL	$7.05 - $10.5 $329,848 - $491,263	-46,787 Reduced 5.38%	822,601 $8.64 Million
Q3 2022 Nov 14, 2022	SELL	$5.25 - $9.27 $5,964 - $10,530	-1,136 Reduced 0.13%	869,388 $6.92 Million
Q2 2022 Aug 15, 2022	BUY	$4.69 - $13.25 $4.08 Million - $11.5 Million	870,524 New	870,524 $4.44 Million

Others Institutions Holding MLTX

# of Institutions

157

Shares Held

54.8M

Call Options Held

799K

Put Options Held

661K

View Full List

About MoonLake Immunotherapeutics

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2.04B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

More about MLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Moon Lake Immunotherapeutics Transaction History